Advent Life Sciences closes Fund II on GBP145.5m
Advent Life Sciences has closed its Advent Life Sciences Fund II (ALSF II), a GBP145.5 million (USD235 million) venture capital fund raised to seed and build life sciences companies in the UK, Europe and the US. The fund will back entrepreneurs and early-stage and mid-stage companies with the potential to

